These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34254870)

  • 1. Therapeutic Perspective of Temozolomide Resistance in Glioblastoma Treatment.
    Xia Q; Liu L; Li Y; Zhang P; Han D; Dong L
    Cancer Invest; 2021 Sep; 39(8):627-644. PubMed ID: 34254870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization.
    Garnier D; Meehan B; Kislinger T; Daniel P; Sinha A; Abdulkarim B; Nakano I; Rak J
    Neuro Oncol; 2018 Jan; 20(2):236-248. PubMed ID: 29016925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.
    Tomar MS; Kumar A; Srivastava C; Shrivastava A
    Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188616. PubMed ID: 34419533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioblastoma stem cells deliver ABCB4 transcribed by ATF3 via exosomes conferring glioblastoma resistance to temozolomide.
    Xu X; Zheng Y; Luo L; You Z; Chen H; Wang J; Zhang F; Liu Y; Ke Y
    Cell Death Dis; 2024 May; 15(5):318. PubMed ID: 38710703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme.
    Ho KH; Cheng CH; Chou CM; Chen PH; Liu AJ; Lin CW; Shih CM; Chen KC
    Pharmacol Res; 2019 Sep; 147():104390. PubMed ID: 31398406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma.
    Jiapaer S; Furuta T; Tanaka S; Kitabayashi T; Nakada M
    Neurol Med Chir (Tokyo); 2018 Oct; 58(10):405-421. PubMed ID: 30249919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH as a potential therapeutic target to improve temozolomide antitumor efficacy : A mechanistic modeling study.
    Stéphanou A; Ballesta A
    Pharmacol Res Perspect; 2019 Feb; 7(1):e00454. PubMed ID: 30705757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent HCMV infection of a glioblastoma cell line contributes to the development of resistance to temozolomide.
    Singh P; Neumann DM
    Virus Res; 2020 Jan; 276():197829. PubMed ID: 31790777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers.
    Ntafoulis I; Kleijn A; Ju J; Jimenez-Cowell K; Fabro F; Klein M; Chi Yen RT; Balvers RK; Li Y; Stubbs AP; Kers TV; Kros JM; Lawler SE; Beerepoot LV; Kremer A; Idbaih A; Verreault M; Byrne AT; O'Farrell AC; Connor K; Biswas A; Salvucci M; Prehn JHM; Lambrechts D; Dilcan G; Lodi F; Arijs I; van den Bent MJ; Dirven CMF; Leenstra S; ; Lamfers MLM
    Br J Cancer; 2023 Oct; 129(8):1327-1338. PubMed ID: 37620410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma.
    Zeng A; Wei Z; Yan W; Yin J; Huang X; Zhou X; Li R; Shen F; Wu W; Wang X; You Y
    Cancer Lett; 2018 Nov; 436():10-21. PubMed ID: 30102952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization.
    Li Z; Fu WJ; Chen XQ; Wang S; Deng RS; Tang XP; Yang KD; Niu Q; Zhou H; Li QR; Lin Y; Liang M; Li SS; Ping YF; Liu XD; Bian XW; Yao XH
    J Exp Clin Cancer Res; 2022 Feb; 41(1):74. PubMed ID: 35193644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRPML2 Mucolipin Channels Drive the Response of Glioma Stem Cells to Temozolomide and Affect the Overall Survival in Glioblastoma Patients.
    Morelli MB; Nabissi M; Amantini C; Maggi F; Ricci-Vitiani L; Pallini R; Santoni G
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformed astrocytes confer temozolomide resistance on glioblastoma via delivering ALKBH7 to enhance APNG expression after educating by glioblastoma stem cells-derived exosomes.
    Liu X; Liu L; Wu A; Huang S; Xu Z; Zhang X; Li Z; Li H; Dong J
    CNS Neurosci Ther; 2024 Feb; 30(2):e14599. PubMed ID: 38332576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms and Antitumor Activity of a Binary EGFR/DNA-Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide.
    Sharifi Z; Abdulkarim B; Meehan B; Rak J; Daniel P; Schmitt J; Lauzon N; Eppert K; Duncan HM; Petrecca K; Guiot MC; Jean-Claude B; Sabri S
    Clin Cancer Res; 2019 Dec; 25(24):7594-7608. PubMed ID: 31540977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.
    Yin J; Ge X; Shi Z; Yu C; Lu C; Wei Y; Zeng A; Wang X; Yan W; Zhang J; You Y
    Theranostics; 2021; 11(4):1763-1779. PubMed ID: 33408780
    [No Abstract]   [Full Text] [Related]  

  • 16. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
    Chen Z; Wei X; Shen L; Zhu H; Zheng X
    Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current advances in temozolomide encapsulation for the enhancement of glioblastoma treatment.
    Iturrioz-Rodríguez N; Sampron N; Matheu A
    Theranostics; 2023; 13(9):2734-2756. PubMed ID: 37284445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma.
    Saha D; Rabkin SD; Martuza RL
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas.
    Yin AA; He YL; Etcheverry A; Liu YH; Aubry M; Barnholtz-Sloan J; Liu BL; Mosser J; Lu ZF; Zhang X
    Clin Epigenetics; 2019 May; 11(1):76. PubMed ID: 31088577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Intracellular Cholesterol in Temozolomide-Induced Glioblastoma Cell Death.
    Yamamoto Y; Sasaki N; Kumagai K; Takeuchi S; Toyooka T; Otani N; Wada K; Narita Y; Ichimura K; Namba H; Mori K; Tomiyama A
    Neurol Med Chir (Tokyo); 2018 Jul; 58(7):296-302. PubMed ID: 29899179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.